drugset / Trial / NCT02778880

Pain Reduction With Intranasal Medications for Extremity Injuries

NCT02778880

Phase 3 Completed 90 enrolled Children's Hospital Medical Center, Cincinnati
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study compares the analgesic effect of intranasal sub-dissociative dosing of ketamine and intranasal fentanyl in children presenting to the Emergency Department with acute extremity injuries.

Timeline

Start
2016-03-31
Primary completion
2017-02-22
Completion
2017-03-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 2 ug/kg Intranasal
Subject Ketamine Small molecule 1.5 mg/kg Intranasal

Indications

No indication recorded.